BioSpace News Archive

SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has named Mr. Donghoon Lee, Executive Vice President and Head of Bio Investment Center of SK Inc., as the new Chief Executive Officer and President of SK Biopharmaceuticals and its U.S. subsidiary SK Life Science.

The University of Texas Medical Branch has been awarded a project agreement worth up to $87.4 million by the U.S. DOD’s JPEO-CBRND and the U.S. Department of HHS’ Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response, through the Medical CBRN Defense Consortium Other Transaction Authority, for the development of a vaccine technology against advanced and emerging viral threats.

Calgary, Alberta--(Newsfile Corp. - November 30, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company”) thanks Mr. Neim Malo, founder of Beefstro’s, for his ACP-01 testimonial interview now available on YouTube (https://youtu.be/1ezFC0oIU9s).

Nimble Therapeutics, an industry-leading peptide therapeutics company, today announced the appointment of Pete Gough, D. Phil. as Chief Scientific Officer (CSO).

The global neuroscience antibodies and assays market size was USD 3.20 Billion in 2020 and is expected to register a CAGR of 10.4% during the forecast period.

The global advanced therapy medicinal products CDMO market size is expected to be worth around US$ 20.9 billion by 2030, according to a new report by Vision Research Reports.

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced the appointment of Christine Foster, Ph.D. to the role of Chief Business Officer.

HemoSonics, LLC, a leading medical device company delivering individualized diagnostic solutions for Patient Blood Management (PBM), announced today that it has received 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for the Quantra Hemostasis System with QStat Cartridge.

Biofrontera Inc. announced that the Company will be participating in Benchmark’s 11th Annual Discovery One-on-One Investor Conference being held on December 1, 2022 in New York, NY.

The global amniotic membrane market size is expected to be worth around US$ 6.81 billion by 2030, according to a new report by Vision Research Reports.